Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Newest in this topic

  1. Clinical genetics and genetic counseling in the era of disease-modifying therapies for dementia: lessons from Japan 2026-11-04
  2. The impact of demographic, clinical, genetic, and imaging variables on tau PET status 2020-11-19
  3. Cerebrospinal Fluid YKL-40 and Chitotriosidase Levels in Frontotemporal Dementia Vary by Clinical, Genetic and Pathological Subtype 2020-04-28

Studies

3 studies carry this tag.

Date range

2020 to 2026

Top journals

  • Dementia and geriatric cognitive disorders 1
  • European journal of nuclear medicine and molecular imaging 1
  • Journal of human genetics 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Clinical genetics and genetic counseling in the era of disease-modifying therapies for dementia: lessons from Japan

    ✓ Peer-reviewed alzhub usefulness score 47 out of 100. Journal of human genetics 2026-11-04 Treatments

    Recent advances in hereditary dementia research have clarified its molecular pathogenesis and clinical applications, with several advances already reaching implementation.

  2. The impact of demographic, clinical, genetic, and imaging variables on tau PET status

    ✓ Peer-reviewed alzhub usefulness score 57 out of 100. European journal of nuclear medicine and molecular imaging 2020-11-19 Brain scans and imaging

    We identified several demographic, clinical, and neurobiological factors that are important to explain the variance in tau PET retention observed across the AD pathological continuum, non-AD neurodegenerative disorders, and cognitively unimpaired persons.

  3. Cerebrospinal Fluid YKL-40 and Chitotriosidase Levels in Frontotemporal Dementia Vary by Clinical, Genetic and Pathological Subtype

    ✓ Peer-reviewed alzhub usefulness score 45 out of 100. Dementia and geriatric cognitive disorders 2020-04-28 Biomarkers

    CSF YKL-40 and chitotriosidase levels are increased in individuals with clinical FTD syndromes, particularly due to AD pathology.

All topic tags with their study counts